— Know what they know.
Not Investment Advice

PACB NASDAQ

Pacific Biosciences of California, Inc.
1W: +3.3% 1M: -26.9% 3M: -22.4% YTD: -32.1% 1Y: +22.6% 3Y: -89.8% 5Y: -94.7%
$1.22
-0.03 (-2.40%)
 
Weekly Expected Move ±12.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 29 · $378.9M mcap · 302M float · 1.99% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$160M
Revenue
+5.0% YoY
$-129M
Net Income
+80.5% YoY
$-116M
Free Cash Flow
+36.5% YoY
34.5%
Gross Margin
-102.0%
Op. Margin
-22.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-50.2%
ROA-12.6%
ROIC-26.5%

Valuation

P/E-2.9
P/B157.7
EV/EBITDA-6.0

Leverage

Debt/Equity141.98
Current Ratio6.89
Interest Cov.-44.7x

Quality Scores

Piotroski F4/9
Altman Z-4.46
Beneish M-3.15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms